Claudia T Martorell MD MPH FACP (She/Her)
HIV/AIDS Medicine, Mycobacterial Disease, STD Medicine
Director and Principal Investigator, The Research Institute
Join to View Full Profile
57 Mulberry St.Springfield, MA 01105
Phone+1 413-747-5566
Fax+1 413-747-5666
Dr. Martorell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board Certified Infectious Diseases Physician; MPH
Clinical Investigator in HIV/HCV/PreP/STI/other
Expertise: Infectious Diseases, HIV/HCV, HBV, STI ,PreP, DoxyPEP, Gender Affirming Care, Substance Use,Disease Prevention/Public Health, Health Care Management, Health Policy/Minority Health Policy, Minority Health Care, Health Care Disparities, CME Education, Consulting, and Clinical Research
Clinical Expertise
- Viral hepatitides, Hepatitis C, Skin infections, Herpes zoster, Lyme disease, Pneumonia, Sinusitis, Clostridium difficile colitis, Helicobacter pylori infection, Urinary tract infections, HIV/AIDS, Tick-borne diseases, Influenza, Fungal infections, Bacterial vaginosis, Mycobacterial infections, Public health, Sexually transmitted disease screening, Infectious disease, Women's health, Osteomyelitis, Sexually transmitted infections, Health policy, Telemedicine, Healthcare disparities, Minority health, Substance abuse, Opiate dependence, Vaccines, Methicillin-resistant staphylococcus aureus, Bacterial vaginitis, Transgender Care, PrEP, Infusion Therapy, COVID-19, DoxyPEP, USCIS- Civil Surgeon I-693, Long Term Injectable ART
Education & Training
Harvard UniversityFellowship Health Policy, Fellowship in Minority Health Policy, 2003 - 2004- Harvard School of Public HealthMPH, Health Care Management, 2003 - 2004
UMass Chan - BaystateFellowship, Infectious Disease, 2003- UMass Chan - BaystateResidency, Internal Medicine, 1998 - 2001
University of Puerto RicoInternship, Internal Medicine, 1998 - 1999
Certifications & Licensure
FL State Medical License 2023 - 2027
MA State Medical License 2003 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Care360 EHR, Quest Diagnostics Incorporated, 2012, 2014-2017
Clinical Trials
- Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C Start of enrollment: 2009 Aug 01
- Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care Start of enrollment: 2009 Dec 01
- Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV care.Ellen Eaton, Claudia T Martorell, Jewel Sawyer, Tanya S Schreibman, Gregory S Felzien
HIV Research & Clinical Practice. 2025-12-01 - Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series.Charlotte Rolle, Amit Achhra, Christina Harbison, Diana Finkel, Christopher Lucasti
Clinical Infectious Diseases. 2025-11-03 - 2 citationsHIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-lab...David A Wohl, Christoph D Spinner, Jason Flamm, C Bradley Hare, Susanne Doblecki-Lewis
The Lancet. HIV. 2024-08-01
Journal Articles
- Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide from Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, F...E S Daar, O Osiyemi, D Porter, M Thompson, C Martorell, HIV Medicine
Press Mentions
Healthcare Watch November 2022November 22nd, 2022- Sermo Surveys Reveals 87% of Global Physicians Feel There Is a Lack of Clinical Guidelines on How to Treat Long Covid in Patients SOctober 12th, 2022
Committees
- Medical Advisory Board, Sermo 2022 - Present
- Medical Advisory Board, Doximity 2023 - 2023
Professional Memberships
- Member
- Fellow
- Infectious Disease Society of America - IDSAMember
- IASMember
- NHMAMember
Other Languages
- Spanish, French
Industry Relationships
- HIV Speaker-CME, PRIME
- HIV Speaker Bureau- CME, Simply Speaking
- HCV Speaker Bureau, AbbVie
- Speaker Bureau, Theratechnologies
- HIV and PreP Speaker Bureau, ViiV
External Links
- Claudia Martorell MDhttp://www.idresearchinstitute.com
- Linked INhttp://Www.linkedin.com/in/claudiamartorell
- Facebookhttp://facebook.com/TheResearchInstitute
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
